Enablers and barriers for supply chain finance investments in Pharma 4.0: a study in the Indian context using total interpretive structural modelling
by Jude Jegan Joseph Jerome; Vandana Sonwaney; O.N. Arunkumar
International Journal of Revenue Management (IJRM), Vol. 14, No. 2, 2024

Abstract: In this study, we examine the conditions that surround the investment made into Pharma 4.0 by the supply chain finance institution. This study analyses the various enablers and barriers that would affect the implementation of Pharma 4.0, through the investment by an SCF institution, in the Indian pharmaceutical manufacturing firms. To establish the linkage between the factors, total interpretive structural modelling is used. MICMAC is used to prioritise the factors and develop suitable strategies. The findings show that a combined effort of all the stakeholders is required for eliminating the barriers to the implementation. The findings also give information about the various enablers that would help catalyse the adoption of Pharma 4.0. This study talks about how SCF investment, usually seen as a short-term investment, can be used with the long-term perspective to gain benefits and incentives through investment in Pharma 4.0 by properly monitoring and controlling the influencing factors.

Online publication date: Wed, 29-May-2024

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Revenue Management (IJRM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com